Moreover, a membrane-permeable blocking peptide (TAT-R1D), which targets the DAPK1-tau binding peptide, blocks the formation of the complex and tau phosphorylation, significantly reducing the infarct area and neuronal loss induced by ischemic stroke [103]. The gene discussed is MAPT; the disease is ischemic stroke.